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The purpose of this paper is to review clinical studies on hypophosphatemia in pediatric intensive care unit patients
with a view to verifying prevalence and risk factors associated with this disorder.
We searched the computerized bibliographic databases Medline, Embase, Cochrane Library, and LILACS to identify
eligible studies. Search terms included critically ill, pediatric intensive care, trauma, sepsis, infectious diseases, malnutrition,
inflammatory response, surgery, starvation, respiratory failure, diuretic, steroid, antiacid therapy, mechanical ventilation.
The search period covered those clinical trials published from January 1990 to January 2004. Studies concerning
endocrinological disorders, genetic syndromes, rickets, renal diseases, anorexia nervosa, alcohol abuse, and prematurity
were not included in this review.
Out of 27 studies retrieved, only 8 involved pediatric patients, and most of these were case reports. One clinical trial and
one retrospective study were identified. The prevalence of hypophosphatemia exceeded 50%.
The commonly associated factors in most patients with hypophosphatemia were refeeding syndrome, malnutrition,
sepsis, trauma, and diuretic and steroid therapy. Given the high prevalence, clinical manifestations, and multiple risk
factors, the early identification of this disorder in critically ill children is crucial for adequate replacement therapy and also
to avoid complications.
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Despite the fact that monitoring of
sodium, potassium, and calcium ions
is part of the routine of intensive care
unit services, little attention has been
devoted to phosphorus during the fol-
low-up of critically ill patients.1
Required for many biological func-
tions, phosphorus plays an important
part in metabolism as a main intracel-
lular anion, enzyme constituent, and
component of phosphorylated inter-
mediate compounds, and phosphorus
is also a component in cellular mem-
branes, nucleic acids, and nuclear pro-
teins.2,3,4,5
Approximately 1000 mg of phos-
phorus is the recommended daily al-
lowance for healthy adults, with an av-
erage of 800 mg for normal children.2,6,7
Dietary sources of phosphorus include
protein-rich foods, cereals, and nuts.3
Phosphorus is absorbed in greater
proportions in the jejunum, mainly by
passive transport. Excretion takes
place essentially by the kidneys,
whereby 80% of the phosphorus is
reabsorbed passively within the proxi-
mal tubule, linked with sodium, and
regulated by hormonal action and
food ingestion.2,3,6
Approximately 1% of the body’s
total phosphorus reserve is found in
the blood,3,8 and phosphorus is prima-
rily stored within mineralized tissues
(bone and teeth). Phosphorus is also
present in soft tissues in the form of
phospholipids, phosphoglycides, and
phosphoproteins.2,3,6
Similar to that of calcium,
homeostasis of phosphorus also in-
volves direct participation of the intes-
tine, bones, and kidneys, being main-
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athyroid hormone (PTH), and calci-
tonin. Vitamin D acts in the intestine,
increasing both calcium and phospho-
rus absorption. Phosphatemia, how-
ever, is practically controlled by renal
excretion. PTH secretion, stimulated
by a decrease in calcium serum levels,
acts in renal reabsorption, reducing
urinary excretion of calcium while si-
multaneously inhibiting the tubular
reabsorption of phosphorus. Con-
versely, when calcium levels are high,
calcitonin is released, acting in reverse
fashion, i.e. reducing phosphaturia
while increasing calcium excretion.9
Normal blood concentrations for
phosphorus in children aged 5 or un-
der are shown in Table 1. The lower
limits are cut-off points for diagnosis
of hypophosphatemia. The same clas-
sification as for adults is used in chil-
dren over 5 years old.10 It should be
noted that given that the range of vari-
ation in blood concentrations is wide,
serum levels of 3 to 4 mg/dL in infants
generally indicates hypophos-
phatemia.
In adults, hypophosphatemia is
classified as mild (2-2.5 mg/dL), mod-
erate (1-2 mg/dL), and severe (<1 mg/
dL), while normal levels of phospho-
rus in the blood range between 2.8 and
4.5 mg/dL.6,8
In clinical practice, however, the
maintenance of normal blood concen-
trations takes on greater importance in
those patients at high risk of develop-
ing hypophosphatemia, such as in
malnutrition, refeeding, total parenteral
nutrition with an absence or inad-
equate supply of phosphate, as well as
in sepsis, burns, post-operation, and in
antiacid, diuretics, and/or steroids
use.9
The decreasing of the body’s stores
and increased consumption of phos-
phorus can explain the onset of
hypophosphatemia in malnourished
patients.4 Besides these factors, endo-
crine metabolism changes are ob-
served in systemic inflammatory re-
sponse syndrome (SIRS), along with
interleukin production and elevated
catabolism, which further contribute
toward phosphorus disorders.
In critically ill patients, hypo-
phosphatemia results from chronic
phosphate depletion and cellular re-
distribution. The first mechanism in-
volves situations such as insufficient
intake over prolonged periods (malnu-
trition), reductions in intestinal ab-
sorption (antiacid therapy), and in-
creases in urinary losses (diuretic
therapy). The redistribution condition,
for its part, besides being more fre-
quent in these patients, is commonly
responsible for triggering the more se-
vere form of hypophosphatemia. Res-
piratory alkalosis, high blood concen-
trations of stress hormones (insulin,
glucagon, adrenalin, cortisol), and
refeeding syndrome are the main con-
ditions contributing to phosphate re-
distribution within the organism.5
In the majority of cases, the symp-
toms related to hypophosphatemia are
nonspecific, such as fatigue and irrita-
bility.2 The most important clinical
manifestations, such as acute respira-
tory insufficiency,11,12 arrhythmia,13,14
hypertension, changes in mental state,
and generalized weakness6,15 are all
generally present in cases of serious
hypophosphatemia.
The aim of this study was to carry
out a review of the literature on the
prevalence, risk factors, and clinical
conditions associated with
hypophosphatemia in critically ill
children.
Selection Criteria
The following criteria were used to
select the included reports:
- Publications stored in the Medline,
Embase, and Cochrane Library
databases or publications and an-
nals from congresses specializing
in intensive pediatric care; pub-
lished between January 1990 and
January 2004;
- Clinical studies and case reports
regarding the prevalence and asso-
ciated risk factors in critically ill
patients with hypophosphatemia;
- Participants: patients between 1
month and 18 years of age and of
both sexes;
- Variables: prevalence of hypophos-
phatemia, mortality, length of hos-
pitalization, and associated risk
factors;
- Reports that were identified using
the following search terms: criti-
cally ill, pediatric intensive care,
trauma, sepsis, infection diseases,
malnutrition, inflammatory re-
sponse, surgery, starvation, respi-
ratory failure, mechanical ventila-
tion, and diuretic, steroid, and
antiacid therapy.
Those studies concerning endo-
crine disorders, genetic syndromes,
rickets, renal diseases, anorexia ner-
vosa, alcohol abuse, and prematurity
were excluded.
A total of 27 articles were retrieved;
of these, only 8 were related to
pediatric age groups, where these com-
prised 1 prospective clinical study,16 1
retrospective,17 1 abstract,18 and 5 case
reports.
The prospective study assessed
238 patients diagnosed with acute in-
fection, where the cut-off point for
hypophosphatemia was set at <4 mg/
dL for minors under 1 year of age and
<3.6 mg/dL for patients aged between
1 and 14 years. Hypophosphatemia
varied according to clinical diagnosis
as follows: pneumonia 45%, upper res-
Table 1 - Normal blood levels of
phosphorus in children under 5 years
of age.
Age Group Phosphorus (mg/dL)
Newborn 4.2 to 9.0
1 year 3.8 to 6.2
2-5 years 3.5 to 6.8
Source: Worley et al.10
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piratory tract-related bacterial infec-
tion 35.7%, urinary tract infection
18%, and viral infection 4.4%. The
highest prevalence observed was 61%
in patients with pneumonia and in-
creased C-reactive protein.16
Manary et al.,17 on carrying out a
retrospective study on 68 children un-
der 10 years old with kwashiorkor, us-
ing 3 mg/dL as a lower limit for nor-
mality, found hypophosphatemia in
76% of cases. The authors also verified
a link between severe hypophos-
phatemia (<1 mg/dL) and mortality, re-
porting a 63% death rate in patients
with severe hypophosphatemia.
The case reports described the on-
set of hypophosphatemia in malnour-
ished children during refeeding;10,19 in
adolescents with diagnosed bone
tumor,20 and severe encephalic cranial
trauma.21 In another study, authors
show a case of hypophosphatemia fol-
lowing intravascular hemolysis sec-
ondary to aggressive hyperphospha-
temia correction.22
In the present review, only 30% of
studies identified were related to the
pediatric age group; of these, the ma-
jority described isolated cases.
Among the clinical studies, hypo-
phosphatemia was detected in over
half of patients assessed.16,17 It should
be emphasized, however, that these
studies differed with regard to the se-
rum level limit of phosphorus required
for a diagnosis of hypophosphatemia.
The sole prospective study16 iden-
tified a 61% prevalence in patients
with a diagnosis of pneumonia and
high serum levels of C-reactive protein,
demonstrating significant negative
correlation between serum levels of
phosphate and this acute phase reac-
tant. The results also showed hypo-
phosphatemia to be a transitory con-
dition during the acute phase of infec-
tion, stabilizing before C-reactive pro-
tein concentration becomes normal-
ized. Despite this, it is important to
make clear that the sample did not in-
clude critically ill patients, such sub-
jects being more susceptible to the
deleterious effects of hypophos-
phatemia.
The risk factors most often associ-
ated with hypophosphatemia were
refeeding,10,19 malnutrition,10,17 infec-
tion,16 sepsis,4,23,24 trauma,21 and diuret-
ics9,25 and steroids use.5,9
Severe hypophosphatemia and its
associated complications has been re-
ferred to as refeeding syndrome, espe-
cially in malnourished patients who
have been re-fed rapidly and inappro-
priately through enteral or parenteral
nutrition. In this syndrome, besides
phosphorus depletion, changes gener-
ally occur in the serum levels of po-
tassium and magnesium, as well in hy-
dric balance, glycose metabolism, and
vitamin deficiencies, particularly thia-
min.26
Refeeding syndrome has received
little recognition or study in clinical
practice, especially in the pediatric
population. Questions remain with re-
gard to this issue, since not all patients
undergoing refeeding, even without
electrolyte supplements, develop the
syndrome.19,26 In general, patients at
higher risk tend to include those suf-
fering from severe malnutrition, par-
ticularly where weight loss exceeds
10% during a 2-month period, and
lengthy fasting with evidence of stress
and depletion is present.27 In order to
better understand this, it is necessary
to know the physiopathological me-
chanisms of the syndrome, which are
described below.
In critically ill, malnourished pa-
tients, the serum level of phosphorus
prior to refeeding is usually normal.
However, as the body’s total stores be-
come depleted, there is a risk of devel-
oping hypophosphatemia as the sup-
ply of nutrients increases cell uptake
of phosphorus for synthesis of the
phosphorylated compounds (adenos-
ine triphosphate, 2.3-diphospho-
glycerate) required for the forming of
new tissues.2,3,6,10,19 During fasting, a
reduction in blood concentrations of
insulin takes place; in response to this,
glucagon release increases, which then
stimulates fat and muscle catabolism
to form glycose. Although glyconeo-
genesis is an important mechanism of
adaptation to nutritional deprivation,
it contributes to a loss in muscular
mass, water, and minerals. Neverthe-
less, the serum level of phosphorus,
along with other depleted ions, is kept
at normal levels as a result of adjust-
ments to metabolism. In severe malnu-
trition, daily phosphorus requirements
drop, most likely owing to low inges-
tion, inhibiting the secretion of par-
athyroid hormone and stimulating cal-
citonin release, thereby promoting re-
ductions in renal excretion, increases
in intestinal absorption, and bone rea-
bsorption. With the commencement of
refeeding, carbohydrates become the
main energy source, increasing insulin
secretion, which in turn stimulates the
uptake of glucose, phosphorus, potas-
sium, magnesium, and water by the
cell for anabolism. A combined de-
crease in the body’s stores during fast-
ing, together with increased flow of
ions and water to the interior of the cell,
promotes the onset of hypophos-
phatemia, hypocalcemia, hypomagne-
semia, and edema, which characterize
refeeding syndrome.19,26,27
In order to prevent refeeding syn-
drome, it is recommended that intake
of energy, liquids and electrolytes be
made gradually, particularly over the
first week, during which most compli-
cations tend to take place. Adequate
volemia and caloric intake should be
achieved slowly so as to avoid cardiac
overload and rapid electrolyte
changes.28,29,30 The role of the hospital
nutritional therapy team must be em-
phasized in recognizing and manag-
ing patients with refeeding syndrome,
to carry out routine monitoring of
phosphorus, potassium, and serum lev-
els of magnesium and supplement
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these electrolytes both before and dur-
ing nutrient intake.
Hypophosphatemia has also been
associated with sepsis, which has in-
creased incidence during the first 24
hours of hospitalization.4 In systemic
inflammatory response syndrome
(SIRS), principally secondary to infec-
tion, sepsis, or trauma, a release of hor-
mones and interleukins (mediators of
hypercatabolism) takes place, which
contributes towards hypophospha-
temia. However, the mechanisms in-
volved in the genesis of hypophos-
phatemia during sepsis remain unclear.
A number of authors have suggested
using serum levels of phosphorus as an
early diagnostic marker for sepsis in
adults.23,24
Patients with severe head trauma
are at a high risk of developing hypo-
phosphatemia because of the multiple
associated factors that can trigger this
disorder, such as respiratory alkalosis
and mannitol administration, dextrose
solutions, antiacids, and sodium bicar-
bonate. A study assessing electrolyte
disorders in patients admitted with se-
vere head trauma found that 61% had
hypophosphatemia, whereas those pa-
tients with mild trauma (control
group) had no changes in serum lev-
els of phosphorus. The authors pointed
to increased renal losses due to polyu-
ria and cellular redistribution of phos-
phorus as being possible physiopatho-
logical mechanisms to explain hypo-
phosphatemia.1,21
Drugs, such as furosemide, used for
a prolonged period predispose patients
to hypophosphatemia owing to in-
creased urinary excretion of phospho-
rus9,25 as a result of tissue redistribu-
tion and reduced intestinal absorp-
tion.5,9,31
Hypophosphatemia is responsible
for numerous deleterious conse-
quences, especially in its severe form,
hampering clinical recovery of the pa-
tient and being associated with mor-
bidity and potential mortality.2,9 The
mechanism underlying the majority of
complications arising from hypophos-
phatemia, such as cardiac, respiratory,
neuromuscular, and hematological
dysfunction, is a deficiency in interme-
diate compounds such as adenosine
triphosphate (ATP) and 2.3-diphos-
phoglycerate.9,26
Hypophosphatemia can trigger a
reduction in the contractility of the
myocardium, arrhythmias, and cardio-
myopathies owing to a fall in the in-
tracellular stores of adenosine triphos-
phate available for the cardiac mus-
cle.11,26 Improvements in cardiac func-
tion have been seen following admin-
istration of phosphate in surgical pa-
tients with hypophosphatemia where
presence of sepsis, use of diuretics, and
total parenteral nutrition were the
main risk factors.25
Similarly, the lower availability of
ATP for respiratory muscle contraction
can explain the onset of acute respira-
tory insufficiency.26 The contractility
of the diaphragm appears to be affected
in patients with hypophosphatemia
and acute respiratory insufficiency on
ventilator support, where improved
muscular function has been observed
after phosphorus reposition, allowing
discontinuation of mechanical lung
ventilation.11 In patients with chronic
obstructed pulmonary disease (COPD),
hypophosphatemia may represent the
central hub of a vicious circle, given
its negative effect on respiratory mus-
cle function. Some authors have
shown muscular depletion of phospho-
rus, through biopsies, in approximately
half of those patients suffering from
respiratory insufficiency due to a
COPD diagnosis.12
In the context of the hematological
system, the decline in levels of 2.3
diphosphoglycerate triggered by hypo-
phosphatemia increases hemoglobin’s
affinity for oxygen, thereby causing
tissue hypoxia and leading to changes
in erythrocytes and leukocyte func-
tions, hemolytic anemia, platelet dys-
function, and thrombocytopenia.26
The neuromuscular dysfunction as-
sociated with hypophosphatemia may
also be explained by tissue hypoxia,
which leads to alterations in neuro-
logical function, irritability, confusion,
paralysis, lethargy, paraesthesia, sei-
zure, and coma.2,26
Notwithstanding the lack of pedia-
tric studies on hypophosphatemia con-
cerning critically ill patients, and
given that the only prospective study
has shown the disorder to be transi-
tory, the studies on adults have dem-
onstrated that complications resulting
from hypophosphatemia imply poorer
clinical outcomes.2,11,12,14,26 Timely
identification and correction of this
disorder in patients hospitalized in in-
tensive care units is therefore war-
ranted.
It has been concluded that hypo-
phosphatemia is a metabolic disorder
of high prevalence in critically ill pa-
tients. The main risk associated factors
include refeeding, malnutrition, sys-
temic inflammatory response syn-
drome, and the use of diuretics and
steroids, and the most relevant clini-
cal complications are related to cardio-
vascular and neuromuscular systems.
Given the significant prevalence
found in the pediatric studies
analyzed, the frequent presence of risk
factors in children in intensive care
units, and the potential harmful effects
on the clinical outcome of these pa-
tients, it is advisable to identify those
cases of highest susceptibility for early
diagnosis and intervention, thus al-
lowing normal serum levels of phos-
phorus to be reestablished.
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RESUMO
Menezes FS e col. Hipofosfatemia em
crianças gravemente doentes. Rev.
Hosp. Clin. Fac. Med. S. Paulo
59(5):306-311, 2004.
Este estudo objetivou realizar revi-
são da literatura para verificar preva-
lência, fatores de risco e condições clí-
nicas associadas à hipofosfatemia em
crianças gravemente doentes.
Para a pesquisa foram utilizadas as
bases de dados Medline, Embase,
Cochrane Library, Lilacs abrangendo
estudos clínicos publicados de janei-
ro de 1990 a janeiro de 2004. Os ter-
mos utilizados para pesquisa foram:
critically ill, pediatric intensive care,
desnutrição, sepse, trauma, uso de
diuréticos e corticoesteróides. Consi-
derando-se a elevada prevalência, as
repercussões clínicas e os múltiplos fa-
tores de risco para hipofosfatemia em
crianças internadas em unidade de cui-
dados intensivos, a identificação pre-
coce de pacientes suscetíveis a esse
distúrbio é essencial para o tratamen-
to oportuno e prevenção de complica-
ções.
UNITERMOS: Hipofosfatemia.
Crianças. Desnutrição. Unidade de
Terapia Intensiva Pediátrica. Grave-
mente doente.
trauma, sepsis, infectious diseases,
malnutrition, inflammatory response,
surgery, starvation, respiratory
failure, diuretic, steroid, antiacid
therapy, mechanical ventilation. Fo-
ram excluídos estudos referentes a dis-
túrbios endócrinos, síndromes genéti-
cas, raquitismo, nefropatias, anorexia
nervosa, alcoolismo e prematuridade.
Dos 27 artigos inicialmente iden-
tificados, 8 referiam-se à faixa etária
pediátrica, sendo a maioria deles rela-
tos de casos isolados. Nos estudos clí-
nicos selecionados, a prevalência de
hipofosfatemia foi superior a 50%.
Os principais fatores associados à
hipofosfatemia foram realimentação,
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